Kaynaklar

• Edwards TM, Myers TP. Environmental Exposures and Gene Regulation in Disease Etiology. Environ Health Perspect 2007; 115:1264–1270.
   PubMed Web of Science ®Google Scholar
• Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007; 8: 355–67.
   PubMed Web of Science ®Google Scholar
• Gilbert SF. Ecological developmental biology: developmental biology meets the real world. Dev Biol 2001; 233: 1–12.
   PubMed Web of Science ®Google Scholar
• Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 2004; 56:311–317.
   PubMed Web of Science ®Google Scholar
• Crespi EJ, Denver RJ. Ancient Origins of Human Developmental Plasticity. Am J Human Biology 2005; 17:44–54.
   PubMed Web of Science ®Google Scholar
• Meaney MJ, Szyf M. Maternal care as a model for experience-dependent chromatin plasticity?. Trends Neurosci 2005; 28:456–463.
   PubMed Web of Science ®Google Scholar
• Finch CE, Rose MR. Hormones and the physiological architecture of life-history evolution. Q Rev Biol 1995; 70: 1–52.
   PubMed Web of Science ®Google Scholar
• Jana B, Dzienis A, Rogozinska A, Piskula M, Jedlinska-Krakowska M, Wojtkiewicz J, Majewski M. Dexamethasone-induced changes in sympathetic innervation of porcine ovaries and in their steroidogenic activity. J Reprod Dev 2005; 51:715–725.
   Web of Science ®Google Scholar
• Sloan Erica K, Capitanio John P, Tarara Ross P, Mendoza Sally P, Mason William A, Cole Steve W. Social Stress Enhances Sympathetic Innervation of Primate Lymph Nodes: Mechanisms and Implications for Viral Pathogenesis J Neurosci 2007; 27: 8857–8865.
   Web of Science ®Google Scholar
• Colangelo AM, Mallei A, Johnson PF, Mocchetti I. Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription. Brain Res Mol Brain Res 2004; 124:97–104.
   PubMedGoogle Scholar
• Glennemeier KA, Denver RJ. Developmental changes in interrenal responsiveness in anuran amphibians. Integrative and Comparative Biology 2002; 42:565–573.
   Web of Science ®Google Scholar
• Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 2001; 24:1161–1192.
   PubMed Web of Science ®Google Scholar
• McEwen B.S, Wingfield, J.C. The concept of allostasis in biology and medicine, Horm Behav 2003; 43:2–15.
   PubMed Web of Science ®Google Scholar
• Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000; 284:592–597.
   PubMed Web of Science ®Google Scholar
• Stuffrein-Roberts S, Joyce PR, Kennedy MA. Role of epigenetics in mental disorders. Aust N Z J Psychiatry 2008; 42:97–107.
   PubMed Web of Science ®Google Scholar
• Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004; 20:63–68.
   PubMed Web of Science ®Google Scholar
• Sweatt J.D. Experience-dependent epigenetic modifications in the central nervous system. Biol Psychiatry 2009; 65: 191–197.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Maloney B, and Zawia NH. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 2009; 14:992–1003.
   PubMed Web of Science ®Google Scholar
• Rutten BP, Mill J. Epigenetic Mediation of Environmental Influences in Major Psychotic Disorders. Schizophr Bull 2009; 35: 1045–1056.
   PubMed Web of Science ®Google Scholar
• Gissot M, Kelly KA, Ajioka JW, Greally JM, Kim K. Epigenomic Modifications Predict Active Promoters and Gene Structure in Toxoplasma gondii. PLoS Pathog 2007; 3(6):e77.
   Web of Science ®Google Scholar
• GISSOT M, KIM K. How Epigenomics Contributes to the Understanding of Gene Regulation in Toxoplasma gondii. J Eukaryot Microbiol 2008; 55:476–480.
   PubMed Web of Science ®Google Scholar
• Bora G, Erdem-Yurter H. Epigenetik Hastalıklar ve Tedavi Yaklaşımları. Hacettepe Tıp Dergisi 2007; 38:48–54.
   Google Scholar
• Kiefer JC. Epigenetics in development. Dev Dyn 2007; 236: 1144–56.
   PubMed Web of Science ®Google Scholar
• Quina AS, Buschbeck M, Di Croce L. Chromatin structure and epigenetics. Biochem Pharmacol 2006; 72: 1563–1569.
   PubMed Web of Science ®Google Scholar
• Verma M, Srivastava S. Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol 2002; 3:755–763.
   PubMed Web of Science ®Google Scholar
• Lu Q, Qiu X, Hu N, Wen H, Su Y, Richardson BC. Epigenetics, disease, and therapeutic interventions. Ageing Res Rev 2006; 5:449–67.
   PubMed Web of Science ®Google Scholar
• Santos-Rebouças CB, Pimentel MM. Implication of abnormal epigenetic patterns for human diseases. Eur J Hum Genet 2007; 15: 10–17.
   PubMed Web of Science ®Google Scholar
• Cervoni N, Szyf M. Demethylase Activity Is Directed by Histone Acetylation. J Biol Chem 2001; 276:40778–40787.
   PubMed Web of Science ®Google Scholar
• Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395–2402.
   PubMed Web of Science ®Google Scholar
• Pauler FM, Barlow DP. Imprinting mechanisms—it only takes two. Genes Dev 2006; 15;20: 1203–1206.
   Web of Science ®Google Scholar
• Reik W, Dean W, Walter J. Epigenetic Reprogramming in Mammalian Development. Science 2001; 293: 1089–1093.
   PubMed Web of Science ®Google Scholar
• Mansour A. Epigenetic activation of genomic retrotransposons. Journal of Cell and Molecular Biology 2007; 6:99–107.
   Google Scholar
• Meaney MJ, Szyf M, Seckl JR. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol Med 2007; 13:269–277.
   PubMed Web of Science ®Google Scholar
• Akbarian S, Huang HS. Epigenetic Regulation in Human Brain-Focus on Histone Lysine Methylation. Biol Psychiatry 2009; 65: 198–203.
   PubMed Web of Science ®Google Scholar
• Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, Costa E. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 2005; 28;102:9341–9346.
   Web of Science ®Google Scholar
• Veldic M, Guidotti A, Maloku E, Davis JM, Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci U S A 2005; 102:2152–2157.
   PubMed Web of Science ®Google Scholar
• Huang HS, Matevossian A, Whittle C, Kim SY, Schumacher A, Baker SP, Akbarian S. Prefrontal dysfunction in schizophrenia involves mixedlineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 2007; 27: 11254–11262.
   PubMed Web of Science ®Google Scholar
• Peedicayil J. The role of epigenetics in mental disorders. Indian J Med Res 2007; 126: 105–111.
   PubMed Web of Science ®Google Scholar
• Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE, Truong HT, Russo SJ, Laplant Q, Sasaki TS, Whistler KN, Neve RL, Self DW, Nestler EJ. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005; 48:303–314.
   PubMed Web of Science ®Google Scholar
• Nestler JE. The neurobiology of cocaine addiction. Sci Pract Perspect. 2005; 3:4–10.
   PubMedGoogle Scholar
• Renthal W, Maze I, Krishnan V, Covington HE 3rd, Xiao G, Kumar A, Russo SJ, Graham A, Tsankova N, Kippin TE, Kerstetter KA, Neve RL, Haggarty SJ, McKinsey TA, Bassel-Duby R, Olson EN, Nestler EJ. Histone deacetylase 5 epigenetically controls behavioural adaptations to chronic emotional stimuli. Neuron 2007; 56:517–529.
   PubMed Web of Science ®Google Scholar
• Bowden CL. Spectrum of effectiveness of valproate in neuropsychiatry. Expert Rev Neurother 2007; 7:9–16.
   PubMedGoogle Scholar
• Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 1998; 95:3003–3007.
   PubMed Web of Science ®Google Scholar
• Lain S, Hollick JJ, Campbell J, Staples OD, Higgins M, Aoubala M, McCarthy A, Appleyard V, Murray KE, Baker L, Thompson A, Mathers J, Holland SJ, Stark MJ, Pass G, Woods J, Lane DP, Westwood NJ. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 2008; 13:454–463.
   PubMed Web of Science ®Google Scholar
• Abel T, Zukin RS. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 2008; 8:57–64.
   PubMed Web of Science ®Google Scholar
• Deutsch S, Rosse R, Mastropaolo J, Long K, Gaskins B. Epigenetic therapeutic strategies for the treatment of neuropsychiatric disorders: ready for prime time? Clin Neuropharmacol 2008; 31: 104–119.
   PubMed Web of Science ®Google Scholar
• Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Ann Rev Pharmacol Toxicol 2009; 49:243–263.
   PubMed Web of Science ®Google Scholar
• Sharma RP. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophr Res 2005; 72:79–90.
   PubMed Web of Science ®Google Scholar